BCG-osis and Hematopoietic Cell Transplant for Primary Immunodeficiencies

Anthony Sabulski^{1

2}, Stella M Davies^{3

4}, Grant Paulsen^{3

5}, Rebecca Marsh^{3

4}, Sharat Chandra^{3

4}

Affiliations

¹ Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA. Anthony.Sabulski@cchmc.org.
² Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave, Cincinnati, OH, 45229, USA. Anthony.Sabulski@cchmc.org.
³ Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
⁴ Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave, Cincinnati, OH, 45229, USA.
⁵ Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.

Anthony Sabulski et al. J Clin Immunol. 2021 Feb.

. 2021 Feb;41(2):491-494.

doi: 10.1007/s10875-020-00924-1. Epub 2020 Nov 20.

Anthony Sabulski^{1

2}, Stella M Davies^{3

4}, Grant Paulsen^{3

5}, Rebecca Marsh^{3

4}, Sharat Chandra^{3

4}

¹ Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA. Anthony.Sabulski@cchmc.org.
² Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave, Cincinnati, OH, 45229, USA. Anthony.Sabulski@cchmc.org.
³ Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
⁴ Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave, Cincinnati, OH, 45229, USA.
⁵ Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.

No abstract available

References

1. Marciano BE, Huang CY, Joshi G, Rezaei N, Carvalho BC, Allwood Z, et al. BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policies. J Allergy Clin Immunol. 2014;133(4):1134–41. - DOI
1. Laberko A, Yukhacheva D, Rodina Y, Abramov D, Konovalov D, Radygina S, et al. BCG-related inflammatory syndromes in severe combined immunodeficiency after TCRαβ+/CD19+ depleted HSCT. J Clin Immunol. 2020;40:625–36. - DOI
1. Amayiri N, Al-Zaben A, Ghatasheh L, Frangoul H, Hussein AA. Hematopoietic stem cell transplantation for children with primary immunodeficiency diseases: single center experience in Jordan. Pediatr Transplant. 2013;17(4):394–402. - DOI
1. Talbot EA, Perkins MD, Silva SF, Frothingham R. Disseminated bacille Calmette-Guérin disease after vaccination: case report and review. Clin Infect Dis. 1997;24(6):1139–46. - DOI
1. Marsh RA, Rao MB, Gefen A, Bellman D, Mehta PA, Khandelwal P, et al. Experience with alemtuzumab, fludarabine, and melphalan reduced-intensity conditioning hematopoietic cell transplantation in patients with nonmalignant diseases reveals good outcomes and that the risk of mixed chimerism depends on underlying disease, stem cell source, and alemtuzumab regimen. Biol Blood Marrow Transplant. 2015;21(8):1460–70. - DOI